Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Nature Communications|November 26, 2016
Genome-wide RNAi screening identifies TMIGD3 isoform1 as a suppressor of NF-κB and osteosarcoma progressionSwathi V Iyer, Atul Ranjan, Harold K Elias, et al.
Cancers|September 9, 2022
Mutant p53 Depletion by Novel Inhibitors for HSP40/J-Domain Proteins Derived from the Natural Compound PlumbaginMohamed Alalem, Mrinalini Bhosale, Atul Ranjan, et al.
Cell Death and Differentiation|December 15, 2017
The interplay between mutant p53 and the mevalonate pathwayAlejandro Parrales, Elizabeth Thoenen, Tomoo Iwakuma
Pharmacology & Therapeutics|July 6, 2019
TP53 in bone and soft tissue sarcomasElizabeth Thoenen, Amanda Curl, Tomoo Iwakuma
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|March 29, 2024
"The 10th International MDM2 Workshop": Opening up new avenues for MDM2 and p53 research, the First International MDM2 Workshop in AsiaRieko Ohki, Koji Itahana, Tomoo Iwakuma
Cell Cycle (Georgetown, Tex.)|May 27, 2005
Li-Fraumeni syndrome: a p53 family affairTomoo Iwakuma, Guillermina Lozano, Elsa R Flores
Nanomedicine : Nanotechnology, Biology, and Medicine|January 10, 2024
Therapeutic potential of combating cancer by restoring wild-type p53 through mRNA nanodeliveryDivya Kamath, Tomoo Iwakuma, Stefan H Bossmann
Frontiers in Bioscience (Landmark Edition)|January 4, 2011
Metastatic potential of tumor-initiating cells in solid tumorsAmit S Adhikari, Neeraj Agarwal, Tomoo Iwakuma
Oncotarget|May 17, 2018
MTBP inhibits the Erk1/2-Elk-1 signaling in hepatocellular carcinomaAtul Ranjan, Swathi V Iyer, Christopher Ward, et al.
Oncogene|June 29, 2021
DNAJA1 promotes cancer metastasis through interaction with mutant p53Atsushi Kaida, Satomi Yamamoto, Alejandro Parrales, et al.
Pageof 7